Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol. 2026;9;111–115. https://doi.org/10.1016/j.euo.2025.11.005: Robotics Is Not Important Because It Is Robotic
Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol. 2026;9;111–115. https://doi.org/10.1016/j.euo.2025.11.005: Robotics Is Not Important Because It Is Robotic. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126001367?dgcid=rss_sd_all
Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol. 2026;9;111–115. https://doi.org/10.1016/j.euo.2025.11.005: Robotics Is Not Important Because It Is Robotic. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126001367?dgcid=rss_sd_all
“Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol. 2026;9;111–115. https://doi.org/10.1016/j.euo.2025.11.005: Robotics Is Not Important Because It Is Robotic.” European Urology Oncology.
@article{article100160,
title = {Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol. 2026;9;111–115. https://doi.org/10.1016/j.euo.2025.11.005: Robotics Is Not Important Because It Is Robotic},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126001367?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...